Karen Akinsanya's most recent trade in Nautilus Biotechnology Inc was a trade of 45,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nautilus Biotechnology Inc | Karen Akinsanya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 14 Apr 2025 | 13,378 | 29,003 (0%) | 0% | 3.2 | 43,077 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 13,378 | 0 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 14 Apr 2025 | 8,378 | 23,970 (0%) | 0% | 25.1 | 210,391 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 14 Apr 2025 | 5,000 | 18,970 (0%) | 0% | 25.1 | 125,555 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 3,345 | 0 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 14 Apr 2025 | 3,345 | 15,625 (0%) | 0% | 25 | 83,625 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 14 Apr 2025 | 3,345 | 32,348 (0%) | 0% | 2.9 | 9,767 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 15,625 | 15,625 (0%) | 0% | 0 | Common Stock | |
| Nautilus Biotechnology Inc | Karen Akinsanya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 63,270 | 63,270 | - | - | Stock Option (right to buy) | |
| Nautilus Biotechnology Inc | Karen Akinsanya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 14,411 | 14,411 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Karen Akinsanya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 105,998 | 105,998 | - | - | Stock Option (Right to Buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Sale of securities on an exchange or to another person at price $ 55.75 per share. | 15 Oct 2021 | 1,393 | 0 (0%) | 0% | 55.8 | 77,660 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2021 | 1,393 | 43,198 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 15 Oct 2021 | 1,393 | 1,393 (0%) | 0% | 4.3 | 6,046 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Sale of securities on an exchange or to another person at price $ 61.13 per share. | 15 Sep 2021 | 1,394 | 0 (0%) | 0% | 61.1 | 85,215 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 1,394 | 44,591 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 15 Sep 2021 | 1,394 | 1,394 (0%) | 0% | 4.3 | 6,050 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Sale of securities on an exchange or to another person at price $ 57.43 per share. | 16 Aug 2021 | 21,691 | 16,047 (0%) | 0% | 57.4 | 1,245,788 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 20,181 | 180,478 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 16 Aug 2021 | 20,181 | 20,181 (0%) | 0% | 17 | 343,077 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Sale of securities on an exchange or to another person at price $ 58.17 per share. | 16 Aug 2021 | 16,047 | 0 (0%) | 0% | 58.2 | 933,526 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 13,377 | 13,378 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 16 Aug 2021 | 13,377 | 37,738 (0%) | 0% | 3.2 | 43,074 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 16 Aug 2021 | 4,180 | 24,361 (0%) | 0% | 4.3 | 18,141 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 4,180 | 45,985 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 07 Jun 2021 | 10,242 | 10,242 (0%) | 0% | 4.3 | 44,450 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 10,242 | 50,165 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Sale of securities on an exchange or to another person at price $ 75.49 per share. | 07 Jun 2021 | 9,442 | 800 (0%) | 0% | 75.5 | 712,777 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 07 Jun 2021 | 6,479 | 6,479 (0%) | 0% | 4.3 | 28,119 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 07 Jun 2021 | 6,479 | 0 (0%) | 0% | 75.1 | 486,566 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 6,479 | 60,407 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Sale of securities on an exchange or to another person at price $ 76.08 per share. | 07 Jun 2021 | 800 | 0 (0%) | 0% | 76.1 | 60,863 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2021 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 18 Dec 2020 | 13,377 | 13,377 (0%) | 0% | 3.2 | 43,074 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2020 | 13,377 | 26,755 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Karen Akinsanya | See Remarks | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 18 Dec 2020 | 13,377 | 0 (0%) | 0% | 80 | 1,070,160 | Common Stock |